Company intelligence / Profile preview
Salix Pharmaceuticals
Bridgewater Township, New Jersey, United Statessalix.com ↗
- Ownership
- Public · SLXP
- Employees
- ~500
- Development stage
- Commercial
01
Overview
Salix has a robust commercial portfolio of prescription drugs and medical devices for GI diseases. Its flagship products include Xifaxan for IBS-D and hepatic encephalopathy. The company continues to develop new therapies in late-stage clinical development through licensing agreements.
- Therapeutic areas
- OtherGastroenterologyInfectious Diseases
- Modalities
- Small moleculesmedical devices
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Mitsubishi Tanabe Pharma Co. – exclusive license agreement for late-stage S1P modulator program targeting IBDPhotocure – strategic global agreement for Lumacan colorectal diagnostic technology
04
Financials
- Market cap
- $88.4M
- Total revenue
- $0
Beyond the preview
Go deeper on Salix Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Salix Pharmaceuticals.